MetLife Investment Management, LLC - CRINETICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,011,725
+100.2%
34,019
+21.3%
0.01%
+100.0%
Q2 2023$505,407
+12.2%
28,0470.0%0.00%
+33.3%
Q1 2023$450,435
-12.2%
28,0470.0%0.00%
-25.0%
Q4 2022$513,260
-4.1%
28,047
+2.9%
0.00%
-20.0%
Q3 2022$535,288
+12.9%
27,255
+7.2%
0.01%
+25.0%
Q2 2022$474,027
-15.0%
25,4170.0%0.00%0.0%
Q1 2022$557,903
+20.1%
25,417
+55.4%
0.00%0.0%
Q4 2021$464,617
+89.5%
16,354
+40.4%
0.00%
+100.0%
Q3 2021$245,190
+11.7%
11,6480.0%0.00%0.0%
Q2 2021$219,565
+23.4%
11,6480.0%0.00%0.0%
Q1 2021$177,981
-0.9%
11,648
-8.5%
0.00%0.0%
Q4 2020$179,649
-10.0%
12,7320.0%0.00%0.0%
Q3 2020$199,510
-10.6%
12,7320.0%0.00%
-33.3%
Q2 2020$223,065
+160.1%
12,732
+118.2%
0.00%
+200.0%
Q1 2020$85,775
-41.4%
5,8350.0%0.00%
-50.0%
Q4 2019$146,400–5,835–0.00%–
 Download
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders